Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: A phase II trial

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 31, Issue 3, 2008, Pages 264-270

  Ballonoff, Ari ^a,b   Kavanagh, Brian ^a   McCarter, Martin ^a   Kane, Madeleine ^a   Pearlman, Nathan ^a   Nash, Russell ^a   Shah, Raj J ^a   Raben, David ^a   Schefter, Tracey E ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Campus Mail Stop F 706 ^*  (United States)

Author keywords

Capecitabine; IMRT; Preoperative; Radiation; Rectal cancer

Indexed keywords

ATROPINE PLUS DIPHENOXYLATE; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; LOPERAMIDE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DISEASE SEVERITY; DRUG SAFETY; EXCISION; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FOLLOW UP; HAND FOOT SYNDROME; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE; MALE; MORNING DOSAGE; NAUSEA; NEUTROPENIA; PATHOLOGIST; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECTUM CARCINOMA; THROMBOCYTOPENIA; TREATMENT RESPONSE; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; CANCER STAGING; CHEMICALLY INDUCED DISORDER; DISEASE FREE SURVIVAL; MIDDLE AGED; PATHOLOGY; PREMEDICATION; RECTUM TUMOR; REMISSION;

ADENOCARCINOMA; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; DIARRHEA; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREMEDICATION; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL NEOPLASMS; REMISSION INDUCTION;

EID: 44949173203     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318161dbd3     Document Type: Article

References (23)

1. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal Cancer. N Engl J Med. 2004;351: 1731-1740.
2. Janjan NA, Crane CN, Feig BW, et al. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal Cancer. Int J Radiat Oncol Biol Phys. 2000;47:713-718.
3. Krishnan S, Janjan NA, Skibber JM, et al. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal Cancer. Int J Radiat Oncol Biol Phys. 2006;66:762-771.
4. Rodel C, Liersch T, Hermann RM, et al. Multicenter phase II trial of chemo-radiation with oxaliplatin for rectal Cancer. J Clin Oncol. 2007;25:110 -117.
5. Gerard J, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol. 2006;24:4620-4625.
6. Bujko K, Nowacki MP, Nasierowska A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal Cancer. Br J Surg. 2006;93:1215-1223.
7. Ryan DP, Niedzwiecki D, Hollis D, et al. Phase I/II study of preopera-tive oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. J Clin Oncol. 2006;24:2557-2562.
8. Mohiuddin M, Winter K, Mitchell E, et al. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol. 2006;24:650-655.
9. Kim JS, Kim JS, Cho MJ, et al. Preoperative chemoradiation using oral capecitabine in locally advanced rectal Cancer. Int J Radiat Oncol Biol Phys. 2002;54:403-408.
10. Kim JC, Kim TW, Kim JH, et al. Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal Cancer. Int J Radiat Oncol Biol Phys. 2005;63:346-353.
11. De Paoli A, Chiara S, Luppi G, et al. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase ii study. Ann Oncol. 2006;17:246-251.
12. Machiels JP, Duck L, Honhon B, et al. Phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with rectal cancer: the radioxcape study. Ann Oncol. 2005;16:1898 -1905.
13. Ruo L, Tickoo S, Klimstra DS, et al. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg. 2000;236:75-81.
14. Van Cutsem E, Twelves C, Cassidy J, et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol. 2000;19:4097-4106.
15. Hoff PM, Ansari R, Batist G, et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol. 2001;19:2282-2292.
16. Twelves C, Wong A, Nowacki M, et al. Capecitabine as adjuvant treatment for stage III colon Cancer. N Engl J Med. 2005;352:2696 -2704.
17. Sawada N, Ishikawa T, Sekiguchi F, et al. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xe-loda) in human cancer xenografts. Clin Cancer Res. 1999;5:2948 -2953.
18. Freedman GM, Meropol NJ, Sigurdson ER, et al. Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal Cancer. Int J Radiat Oncol Biol Phys. 2007;67:1389-1393.
19. Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression grade after preoperative chemoradiotherapy of esoph-ageal carcinoma. Cancer. 1994;73:2680-2686.
20. Vecchio FM, Valentini V, Minsky BD, et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal Cancer. Int J Radiat Oncol Biol Phys. 2005;62:752-760.
21. Jani AB, Su A, Milano MT. Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity. Urology. 2006;67:147-151.
22. Chen MF, Tseng CJ, Tseng CC, et al. Clinical outcome in posthyster-ectomy cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67:1438-1444.
23. NSABP R-04 - a clinical trial comparing preoperative radiation therapy and capecitabine with or without oxaliplatin with preoperative radiation therapy and continuous intravenous infusion of 5-fluorouracil with or without oxaliplatin in the treatment of patients with operable carcinoma of the rectum. Available at www.nsabp.orgwww.nsabp.org. Accessed April 2007.